Pharmalot… Pharmalittle… Good Morning
3 CommentsBy Ed Silverman // February 18th, 2010 // 7:17 am
Hello, everyone. How are you today? We hope your week is going well, despite the assorted meetings and deadlines that are lined up. Our way of coping, of course, is to grab the continual cup of stimulation. So reach for one yourself, or a bottle of water if you prefer, and get ready for another day. As always, here are a few items to help you along. Regards…
Biogen Gets Rights To Hemophilia Drug (Reuters)
Parkinson’s Patients Can Proceed With Addiction Suit (Ottawa Citizen)
Former Searle Exec, Sheldon Gilgore, Dies At 77 (The Wall Street Journal)
Genzyme Earnings Fall On Supply Interruptions (Reuters)
Gilead’s Quad HIV Pill Succeeds In Mid-Stage Study (Reuters)
Coffee pix thx to chichcacha flickr creative commons
pharmavet
I worked for one of Searle’s JV companies in the 1980’s when Dr. Gilgore Searle. Back in more normal times we actually had a company picnic, and I had a chance to Meet “Shelly” as he was affectionately called. Very nice gentleman. Different kind of CEO than Don Rumsfeld, certaily more amiable, and a pretty good CEO as well. Sorry to learn of his passing.
David
Thanks for sharing.
Permax is an interesting medication; dopaminergic medications can have unexpected consequences.
pharmavet
Here is the obit:
http://acorn-online.com/joomla15/darientimes/news/obits/49592-sheldon-g-gilgore-77-former-darien-doctor-was-leader-in-pharmaceutical-industry.html